Literature DB >> 22173518

Frequent hospital readmissions for Clostridium difficile infection and the impact on estimates of hospital-associated C. difficile burden.

Courtney R Murphy1, Taliser R Avery, Erik R Dubberke, Susan S Huang.   

Abstract

OBJECTIVE: Clostridium difficile infection (CDI) is associated with hospitalization and may cause readmission following admission for any reason. We aimed to measure the incidence of readmissions due to CDI.
DESIGN: Retrospective cohort study. PATIENTS: Adult inpatients in Orange County, California, who presented with new-onset CDI within 12 weeks of discharge.
METHODS: We assessed mandatory 2000-2007 hospital discharge data for trends in hospital-associated CDI (HA-CDI) incidence, with and without inclusion of postdischarge CDI (PD-CDI) events resulting in rehospitalization within 12 weeks of discharge. We measured the effect of including PD-CDI events on hospital-specific CDI incidence, a mandatory reporting measure in California, and on relative hospital ranks by CDI incidence.
RESULTS: From 2000 to 2007, countywide hospital-onset CDI (HO-CDI) incidence increased from 15 per 10,000 to 22 per 10,000 admissions. When including PD-CDI events, HA-CDI incidence doubled (29 per 10,000 in 2000 and 52 per 10,000 in 2007). Overall, including PD-CDI events resulted in significantly higher hospital-specific CDI incidence, although hospitals had disproportionate amounts of HA-CDI occurring postdischarge. This resulted in substantial shifts in some hospitals' rankings by CDI incidence. In multivariate models, both HO and PD-CDI were associated with increasing age, higher length of stay, and select comorbidities. Race and Hispanic ethnicity were predictive of PD-CDI but not HO-CDI.
CONCLUSIONS: PD-CDI events associated with rehospitalization are increasingly common. The majority of HA-CDI cases may be occurring postdischarge, raising important questions about both accurate reporting and effective prevention strategies. Some risk factors for PD-CDI may be different than those for HO-CDI, allowing additional identification of high-risk groups before discharge.

Entities:  

Mesh:

Year:  2011        PMID: 22173518      PMCID: PMC3657466          DOI: 10.1086/663209

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  31 in total

1.  Quantifying interhospital patient sharing as a mechanism for infectious disease spread.

Authors:  Susan S Huang; Taliser R Avery; Yeohan Song; Kristen R Elkins; Christopher C Nguyen; Sandra K Nutter; Alaka A Nafday; Curtis J Condon; Michael T Chang; David Chrest; John Boos; Georgiy Bobashev; William Wheaton; Steven A Frank; Richard Platt; Marc Lipsitch; Robin M Bush; Stephen Eubank; Donald S Burke; Bruce Y Lee
Journal:  Infect Control Hosp Epidemiol       Date:  2010-11       Impact factor: 3.254

Review 2.  Constructions of masculinity and their influence on men's well-being: a theory of gender and health.

Authors:  W H Courtenay
Journal:  Soc Sci Med       Date:  2000-05       Impact factor: 4.634

Review 3.  Clostridium difficile colitis.

Authors:  C P Kelly; C Pothoulakis; J T LaMont
Journal:  N Engl J Med       Date:  1994-01-27       Impact factor: 91.245

4.  Health care-associated Clostridium difficile infection in Canada: patient age and infecting strain type are highly predictive of severe outcome and mortality.

Authors:  Mark Miller; Denise Gravel; Michael Mulvey; Geoffrey Taylor; David Boyd; Andrew Simor; Michael Gardam; Allison McGeer; James Hutchinson; Dorothy Moore; Sharon Kelly
Journal:  Clin Infect Dis       Date:  2010-01-15       Impact factor: 9.079

5.  Identifying in-hospital venous thromboembolism (VTE): a comparison of claims-based approaches with the Rochester Epidemiology Project VTE cohort.

Authors:  Cynthia L Leibson; Jack Needleman; Peter Buerhaus; John A Heit; L Joseph Melton; James M Naessens; Kent R Bailey; Tanya M Petterson; Jeanine E Ransom; Marcelline R Harris
Journal:  Med Care       Date:  2008-02       Impact factor: 2.983

Review 6.  Clostridium difficile and inflammatory bowel disease.

Authors:  Mazen Issa; Ashwin N Ananthakrishnan; David G Binion
Journal:  Inflamm Bowel Dis       Date:  2008-10       Impact factor: 5.325

Review 7.  Clostridium difficile associated infection, diarrhea and colitis.

Authors:  Perry Hookman; Jamie S Barkin
Journal:  World J Gastroenterol       Date:  2009-04-07       Impact factor: 5.742

8.  Assessment of Clostridium difficile-associated disease surveillance definitions, North Carolina, 2005.

Authors:  Preeta K Kutty; Stephen R Benoit; Christopher W Woods; Arlene C Sena; Susanna Naggie; Joyce Frederick; John Engemann; Sharon Evans; Brian C Pien; Shailendra N Banerjee; Jeffery Engel; L Clifford McDonald
Journal:  Infect Control Hosp Epidemiol       Date:  2008-03       Impact factor: 3.254

9.  Clostridium difficile infection in Ohio hospitals and nursing homes during 2006.

Authors:  Robert J Campbell; Lynn Giljahn; Kim Machesky; Katie Cibulskas-White; Lisa M Lane; Kyle Porter; John O Paulson; Forrest W Smith; L Clifford McDonald
Journal:  Infect Control Hosp Epidemiol       Date:  2009-06       Impact factor: 3.254

10.  Attributable outcomes of endemic Clostridium difficile-associated disease in nonsurgical patients.

Authors:  Erik R Dubberke; Anne M Butler; Kimberly A Reske; Denis Agniel; Margaret A Olsen; Gina D'Angelo; L Clifford McDonald; Victoria J Fraser
Journal:  Emerg Infect Dis       Date:  2008-07       Impact factor: 6.883

View more
  19 in total

1.  Understanding the current state of infection prevention to prevent Clostridium difficile infection: a human factors and systems engineering approach.

Authors:  Eric Yanke; Caroline Zellmer; Sarah Van Hoof; Helene Moriarty; Pascale Carayon; Nasia Safdar
Journal:  Am J Infect Control       Date:  2015-03-01       Impact factor: 2.918

Review 2.  The economic impact of Clostridium difficile infection: a systematic review.

Authors:  Natasha Nanwa; Tetyana Kendzerska; Murray Krahn; Jeffrey C Kwong; Nick Daneman; William Witteman; Nicole Mittmann; Suzanne M Cadarette; Laura Rosella; Beate Sander
Journal:  Am J Gastroenterol       Date:  2015-04-07       Impact factor: 10.864

3.  The Likelihood of Hospital Readmission Among Patients With Hospital-Onset Central Line-Associated Bloodstream Infections.

Authors:  Carolyn J Khong; James Baggs; David Kleinbaum; Ronda Cochran; John A Jernigan
Journal:  Infect Control Hosp Epidemiol       Date:  2015-05-20       Impact factor: 3.254

4.  Impact of Hospital Population Case-Mix, Including Poverty, on Hospital All-Cause and Infection-Related 30-Day Readmission Rates.

Authors:  Shruti K Gohil; Rupak Datta; Chenghua Cao; Michael J Phelan; Vinh Nguyen; Armaan A Rowther; Susan S Huang
Journal:  Clin Infect Dis       Date:  2015-06-30       Impact factor: 9.079

5.  Disproportionate rise in Clostridium difficile-associated hospitalizations among US youth with inflammatory bowel disease, 1997-2011.

Authors:  Kelly C Sandberg; Matthew M Davis; Achamyeleh Gebremariam; Jeremy Adler
Journal:  J Pediatr Gastroenterol Nutr       Date:  2015-04       Impact factor: 2.839

6.  Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients.

Authors:  Daniel E Freedberg; Hojjat Salmasian; Carol Friedman; Julian A Abrams
Journal:  Am J Gastroenterol       Date:  2013-09-24       Impact factor: 10.864

Review 7.  Initiation of sporulation in Clostridium difficile: a twist on the classic model.

Authors:  Adrianne N Edwards; Shonna M McBride
Journal:  FEMS Microbiol Lett       Date:  2014-06-26       Impact factor: 2.742

8.  Racial Differences in Clostridium difficile Infection Rates Are Attributable to Disparities in Health Care Access.

Authors:  Eric J Mao; Colleen R Kelly; Jason T Machan
Journal:  Antimicrob Agents Chemother       Date:  2015-07-27       Impact factor: 5.191

9.  Treatment of Helicobacter pylori Is Not Associated With Future Clostridium difficile Infection.

Authors:  Shria Kumar; David C Metz; David E Kaplan; David S Goldberg
Journal:  Am J Gastroenterol       Date:  2020-05       Impact factor: 12.045

10.  The impact of the introduction of fidaxomicin on the management of Clostridium difficile infection in seven NHS secondary care hospitals in England: a series of local service evaluations.

Authors:  S D Goldenberg; S Brown; L Edwards; D Gnanarajah; P Howard; D Jenkins; D Nayar; M Pasztor; S Oliver; T Planche; J A T Sandoe; P Wade; L Whitney
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2015-12-12       Impact factor: 3.267

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.